Percutaneous Mechanical Circulatory Support Devices Market Size Forecast To Achieve $3.87 Billion By 2030 With 9.4% CAGR
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Percutaneous Mechanical Circulatory Support Devices Market During The 2026–2030 Period?
The percutaneous mechanical circulatory support devices market has witnessed robust growth in recent years. It is anticipated to increase from $2.46 billion in 2025 to $2.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.7%. Historically, this expansion has been driven by factors such as a rising incidence of cardiovascular diseases, an increase in cardiogenic shock cases, the adoption of minimally invasive procedures, the expansion of ICU care facilities, and an aging population.
The percutaneous mechanical circulatory support devices market is anticipated to experience robust expansion over the coming years. This market is projected to reach $3.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. Key factors contributing to this growth during the forecast period include AI-assisted cardiac monitoring, an increase in complex cardiac interventions, the expansion of cath lab procedures, the rising demand for temporary heart support, and advancements in pump technologies. Significant trends identified for the upcoming period encompass minimally invasive cardiac support, short-term hemodynamic assistance, high-risk PCI support devices, rapid deployment cardiac systems, and designs focused on enhanced patient safety.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp
Which Drivers Are Advancing The Percutaneous Mechanical Circulatory Support Devices Market Growth?
The rising occurrence of cardiovascular diseases is anticipated to fuel the expansion of the percutaneous mechanical circulatory support devices market moving forward. Cardiovascular diseases (CVDs) represent a collection of ailments affecting the heart and blood vessels, covering conditions like coronary artery disease, heart attacks, heart failure, stroke, and high blood pressure. The escalating incidence of these diseases can be attributed to elements such as an aging population, detrimental lifestyle choices, obesity, hypertension, and genetic predisposition. Percutaneous mechanical circulatory support devices are utilized in the context of cardiovascular diseases to enhance cardiac function, lessen strain on the heart, and assist recovery during critical heart conditions. For example, in October 2024, statistics from the Centers for Disease Control and Prevention, a US-based public health institute, revealed that in 2023, around 1 out of every 6 deaths from cardiovascular diseases impacted adults younger than 65 years old, and a total of 919,032 people died from cardiovascular disease, which represented 1 in every 3 deaths. Thus, the growing prevalence of cardiovascular diseases is driving the development of the percutaneous mechanical circulatory support (MCS) devices market.
What Segment Types Are Included In The Percutaneous Mechanical Circulatory Support Devices Market Analysis?
The percutaneous mechanical circulatory support devices market covered in this report is segmented –
1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types
2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices
2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)
3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)
4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System
5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices
Which Trends Are Contributing To Changes In The Percutaneous Mechanical Circulatory Support Devices Market?
Major companies in the percutaneous mechanical circulatory support devices market are concentrating on developing technologically advanced solutions, such as intra-aortic axial-flow devices, to improve patient outcomes and minimize surgical risks. An intra-aortic axial-flow device is a type of percutaneous mechanical circulatory support (MCS) device designed to assist heart function by enhancing blood flow from the left ventricle to the aorta. For instance, in February 2023, Procyrion, Inc., a US-based medical device company, announced the successful first-in-human use of its Aortix pump. This innovative device is intended to prevent acute kidney injury (AKI) in patients undergoing cardiac surgery. Delivered via a catheter in the descending thoracic aorta, the Aortix pump improves renal perfusion while reducing the heart’s workload during surgery. It achieves this by boosting both renal and systemic perfusion and simultaneously decreasing the strain on the heart, making it particularly advantageous for patients with compromised left ventricular function and renal impairment. Capable of delivering up to 5.0 liters of flow per minute, the Aortix pump is intended for temporary use during procedures such as percutaneous coronary interventions (PCI).
Which Key Players Are Active In The Percutaneous Mechanical Circulatory Support Devices Market?
Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.
Access The Complete Percutaneous Mechanical Circulatory Support Devices Market Report:
Which Region Stands As The Largest Contributor To The Percutaneous Mechanical Circulatory Support Devices Market?
North America was the largest region in the percutaneous mechanical circulatory support devices market in 2025. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Percutaneous Mechanical Circulatory Support Devices Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Percutaneous Mechanical Circulatory Support Devices Market 2026, By The Business Research Company
Peripheral Vascular Devices And Equipment Market Report 2026
Cardiovascular Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report
Cardiac Assist Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
